Stem cell transplant patients with HHV-6 reactivation are 15X more likely to reactivate with CMV

Italian investigators found that 87% of patients with HHV-6 reactivations went on to develop a CMV infection. On the other hand, in patients who did not reactivate with HHV-6, only 33% developed an active CMV infection.
miRNA changes by HHV-6A parallel those found in autoimmune thyroid disease

Investigators by at the University of Ferrara report intriguing alterations in intracellular regulation of HHV-6A-infected thyrocytes and T cells. HHV-6A, but not HHV-6B nor HHV-7, altered expression of several microRNAs in a pattern that is considered a marker for patients with autoimmune thyroid disease.
New mouse model for HHV-6 & 7

Investigators at Washington University have sequenced a murine herpesvirus and determined that it is closely related to HHV-6 & 7. Named Murine Rosesolovirus (MRV), the virus causes severe depletion of CD4+ T cells and thymic necrosis in young mice. The authors believe that MRV will be a useful mouse model to study the impact of HHV-6 & 7 in humans.
HHV-6 reactivation and poor CD4+ cell reconstitution predict pediatric acute GVHD

Over a dozen studies have now found HHV-6 to predict aGVHD, but this is the first to correlate viral reactivation with poor CD4+ cell immune reconstitution.

Newsletter | About Us | Contact Us | Donate | Repository

HHV-6 Foundation | HHV-6 Disease Information for Patients, Clinicians, and Researchers | Apply for a Grant

Navigation

Home
About
Patients
Research
Clinicians
Conditions
- Associated Conditions A-H
- Associated Conditions I-Z

Home
About
Patients
Research
Clinicians
Conditions
- Associated Conditions A-H
- Associated Conditions I-Z

Latest Treatments – Alternative Articles

Can a novel free radical scavenger help patients with HHV-6 encephalopathy?

In All, Encephalitis & Encephalopathy, News, Treatments - Alternative by hhv6foundationOctober 27, 2014

Edaravone shows promise for reducing oxidation and neuronal damage in AESD.

Successful use of Artesunate to treat HHV-6B myocarditis in a child

In All, Heart Disease, News, Treatments - Alternative by hhv6foundationApril 4, 2013

A group from Children’s Heart Centre in Lund, Sweden, has used Artesunate as an effective antiviral therapy to aid in the treatment of a child with HHV-6B myocarditis.

Previous Conferences

2017 International Conference Summary

Clinical News

Alzheimer’s Disease
Animal Models
Autoimmune Disease
Bell’s Palsy
Cancer
Chronic Fatigue Syndrome
ciHHV-6
Cognitive Dysfunction
Drug Hypersensitivity
Encephalitis & Encephalopathy
Epilepsy and Seizures
GVHD
Heart Disease
HIV/AIDS Progression
Infertility & Miscarriage
Kidney Disease
Liver Disease
Lymphadenitis
Multiple Sclerosis

Scientific News

Latest Scientific News
Genes & Proteins
Host Cell Interaction
Immunology

About HHV-6

What Is HHV-6?
What is Chromosomally Integrated HHV-6
HHV-6 Repository of Reagents
HHV-6A/B Testing
HHV-6 Treatment

SUBSCRIBE TO OUR NEWSLETTER

ABOUT THE HHV-6 FOUNDATION

The HHV-6 Foundation in a non-profit entity founded to encourage scientific exchange between investigators and to provide pilot grants for promising scientific and clinical research on the under- appreciated viruses HHV-6A and HHV-6B.

The Foundation sponsors international conferences and supports scientists and clinicians seeking to clarify the role of the two HHV-6 viruses in disease. Since HHV-6A and HHV-6B can smolder in the brain and other organs without circulating in the peripheral blood or plasma, identifying chronic infection is a challenge.

HHV-6 Foundation | 1482 East Valley Road, Suite 619 | Santa Barbara, CA, 93108 | Toll Free: (888) 530-6726

WEB DESIGN AND DEVELOPMENT BY INSTYLE TECHNOLOGIES

Home
About
Conditions
Clinicians
Testing
Research
Repository
Patients
Treatment
News & Blog
Donate
Contact Us
Cart
Checkout
Privacy Policy
Terms of Use